Global Anti-aging Drugs Market 2017-2021

Global Anti-aging Drugs Market 2017-2021

Nov 2017 Technavio Infectious Disease96 Pages Price :
$ 3500
About Anti-aging Drugs

Aging can be explained as a process that accumulates changes in an organism over time. It is a continuous process that starts from birth and encompasses several factors such as physical, social, and psychological changes. Although a continuous process, it is seen differently in different phases of age. A babys first tooth is accepted with a much higher positive response than the advent of wrinkles or greying of hair. Youth is highly valued and celebrated in almost all cultures globally, and this provides huge scope for the global anti-aging drugs market. As a person grows older, trillions of cells present in the body change constantly. While many cells get destroyed and die, many new cells also form every minute, which leads to the growth of the body. Aging affects different parts of the body differently. Aging is an inevitable process and common in all organisms. However, there are many factors which contribute to the early or late onset of aging.

Technavios analysts forecast the global anti-aging drugs market to grow at a CAGR of 8.06% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global anti-aging drugs market for 2017-2021. To calculate the market size, the report considers the sales of various drugs in the market.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Anti-aging drugs market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Allergan
Galderma
Merz Pharma
Sanofi
Other prominent vendors
Canbex Therapeutics
Daewoong Pharmaceutical
MMJ PhytoTech
Revitacare
SciVision Biotech

Sun Pharmaceuticals
Suneva Medical
Syneron
Valeant Pharmaceuticals
Market driver
Growing disposable income and healthcare expenditure in developing countries
For a full, detailed list, view our report

Market challenge
Side effects associated with facial aesthetic products use
For a full, detailed list, view our report

Market trend
Technological advancements
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
Market outline
PART 05: MARKET LANDSCAPE
Market overview
Market size and forecast
Five forces analysis
PART 06: MARKET SEGMENTATION BY ROUTE OF ADMINISTRATION (ROA)
Injectable
Oral
Topical
PART 07: REGIONAL LANDSCAPE
Regional comparison
Anti-aging drugs market in Americas
Anti-aging drugs market in EMEA
Anti-aging drugs market in APAC
Key leading countries
Market opportunity
PART 08: DECISION FRAMEWORK
PART 09: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
Competitive landscape
PART 12: KEY VENDOR ANALYSIS
Allergan
Galderma
Merz Pharma
Sanofi
Other prominent vendors
PART 13: APPENDIX
List of abbreviations
List of Exhibits
Exhibit 01: Major aging effects on different parts of the body
Exhibit 02: Factors contributing to early onset of aging
Exhibit 03: Global anti-aging drugs market: Snapshot
Exhibit 04: Global anti-aging drugs market 2016-2021 ($ millions)
Exhibit 05: Five forces analysis
Exhibit 06: Decisive factors for choice of RoA
Exhibit 07: Major RoA for drug intake
Exhibit 08: Global anti-aging drugs market by RoA 2016 ($ millions)
Exhibit 09: Global anti-aging drugs market by RoA 2016-2021 ($ millions)
Exhibit 10: Types of injections
Exhibit 11: Adverse effects of injectable drugs
Exhibit 12: Types of dermal fillers
Exhibit 13: Some common dermal filllers
Exhibit 14: Global anti-aging injectable drugs market 2016-2021 ($ millions)
Exhibit 15: Advantages and disadvantages of oral RoA
Exhibit 16: Global anti-aging oral drugs market 2016-2021 ($ millions)
Exhibit 17: Global anti-aging topical drugs market 2016-2021 ($ millions)
Exhibit 18: Regional landscape
Exhibit 19: Regional comparison
Exhibit 20: Anti-aging drugs market in Americas 2016-2021 (% share)
Exhibit 21: Anti-aging drugs market in Americas Year over year growth
Exhibit 22: Economic and healthcare snapshot of Europe 2014
Exhibit 23: Anti-aging drugs market in EMEA 2016-2021 (& share)
Exhibit 24: Anti-aging drugs market in EMEA Year over year growth
Exhibit 25: Anti-aging drugs market in APAC 2016-2021 (% share)
Exhibit 26: Anti-aging drugs market in APAC Year over year growth
Exhibit 27: Key leading countries
Exhibit 28: Demographic and economic snapshot of India and China
Exhibit 29: World population by age group: 2015-2050
Exhibit 30: Percentage distribution of global population aged 65 years and above by region, 2015-2050
Exhibit 31: Percentage of population aged 60 and above by region, 2015-2050
Exhibit 32: Global average cost of dermal fillers ($)
Exhibit 33: Side effects associated with common anti-aging techniques
Exhibit 34: Competitive structure analysis of global anti-aging drugs market 2016
Exhibit 35: Allergan: Key highlights
Exhibit 36: Allergan: Strength assessment
Exhibit 37: Allergan: Strategy assessment
Exhibit 38: Allergan: Opportunity assessment
Exhibit 39: Galderma: Key highlights
Exhibit 40: Galderma: Strength assessment
Exhibit 41: Galderma: Strategy assessment
Exhibit 42: Galderma: Opportunity assessment
Exhibit 43: Merz Pharma: Key highlights
Exhibit 44: Merz Pharma: Strength assessment
Exhibit 45: Merz Pharma: Strategy assessment
Exhibit 46: Merz Pharma: Opportunity assessment
Exhibit 47: Key highlights
Exhibit 48: Sanofi: Strength assessment
Exhibit 49: Sanofi: Strategy assessment
Exhibit 50: Sanofi: Opportunity assessment

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 3500
$ 5000

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top